Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar
investing succesffuly to reach your goals investing succesffuly to reach your goals
X

Pharmaids Pharmaceuticals Ltd Stock Analysis

Small Cap
Evaluated by 90 users | BSE: 524572 | NSE: |
Trading

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Value Creation
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Capital Employed -3.57%2.22%2.13%-14.57%-3.08%-19.82%-14.02%-31.16%-3.75%0.41%
Growth Parameters
Growth Parameters Colour Code Guide
Net Sales (Rs. Cr.) 0.81.21.31.41.71.71.20.50.60
Y-o-Y Gr. Rt.-59%2.4%11%22.7%-2.9%-28.6%-62.5%24.4%-100%
Adjusted EPS (Rs.) -0.330.110.15-1.04-0.19-1.17-0.75-1.13-0.170.03
Y-o-Y Gr. Rt.-NA36.4%-793.3%NANANANANANA
Book Value per Share (Rs.) 6.196.36.455.45.13.924.253.18.188.21
Adjusted Net Profit -0.100.1-0.4-0.1-0.4-0.3-0.4-0.20
Net Op. Cash Flow (Rs. Cr.) 0.10.30.20.10.200.3-0.2-0.1-0.8
Debt to Cash Flow from Ops 8.421.872.554.421.4128.610000
Standalone financials take only the parent company into account while consolidated financials take into account financials of the parent company as well as of all its subsidiaries. In most companies consolidated financials should be used for analysis.
Pharmaids Pharmaceuticals Ltd. should be analysed on a Standalone basis
CAGR
CAGR Colour Code Guide
  9 yrs 5 yrs 3 yrs 1 yr
Net Sales -100%-100%-100%-100%
Adjusted EPS NANANANA
Book Value per Share 3.21024.50.4
Share Price 21.8% 55.2% 103.1% 320.7%
Key Financial Parameter
Performance Ratio Colour Code Guide
 Mar'11Mar'12Mar'13Mar'14Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20
Return on Equity (%) -5.281.762.38-17.79-3.71-26.21-18.51-31.24-3.760.4
Operating Profit Margin (%) -5.8710.945.85-31.05-5.29-20.51-28.56-85.98-18.130
Net Profit Margin (%) -14.372.994.01-25.21-3.79-23.6-21.13-85.88-31.60
Debt to Equity 0.480.250.20.20.170.360000
Working Capital Days 1,1476936695844243854701,0032,9550
Cash Conversion Cycle 6153703933222052092143593450
Entity Percentage Holding
Promoters 65.81%
Non-Institutions 34.19%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)
Data is not available for this company.

The 5-year analysis of Pharmaids Pharmaceuticals Ltd's performance infers:

Pharmaids Pharmaceuticals Ltd earnings have grown by 0%, whereas share price has appreciated 55.2% CAGR over the past five years, indicating the company's share price is likely overvalued. However, for specific investment actions please connect with your investment advisor.

We analysed the performance of Pharmaids Pharmaceuticals Ltd share prices over the last 10 years. Here is what we found out:

Pharmaids Pharmaceuticals Ltd share price has appreciated 20.8% annually over the past ten years.

No data to display
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback